Academic Underachievement With Tourette, Tic Disorders

Share this content:
Academic Underachievement With Tourette, Tic Disorders
Academic Underachievement With Tourette, Tic Disorders

FRIDAY, June 1, 2018 (HealthDay News) -- Individuals with Tourette syndrome or chronic tic disorders have lower likelihood of academic achievement, according to a study published online May 29 in JAMA Neurology.

Ana Pérez-Vigil, M.D., from the Karolinska Institutet in Stockholm, and colleagues examined the correlation of Tourette syndrome and chronic tic disorders with objectively measured educational outcomes in a population-based birth cohort of individuals born in Sweden from 1976 to 1998. The cohort included 2,115,554 individuals, of whom 3,590 had registered a diagnosis of Tourette syndrome or a chronic tic disorder in specialist care. There were 2,697 families that included siblings discordant for these disorders.

The researchers found that people with Tourette syndrome or chronic tic disorders were significantly less likely to pass all core and additional courses at the end of compulsory school compared with unexposed individuals (odds ratios ranging from 0.23 to 0.36) and to access a vocational program or academic program in upper secondary education (adjusted odds ratios, 0.31 and 0.43, respectively). Individuals with the disorders also had a reduced likelihood of finishing upper secondary education, starting a university degree, and finishing a university degree (adjusted odds ratios, 0.35, 0.41, and 0.39, respectively). In fully-adjusted sibling comparison models, the results were marginally attenuated.

"Help-seeking individuals with Tourette syndrome or chronic tic disorders seen in specialist settings experience substantial academic underachievement across all educational levels," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical publishing industries.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »